NM_000238.4:c.697G>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2

The NM_000238.4(KCNH2):​c.697G>T​(p.Ala233Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000611 in 1,457,400 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A233T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000061 ( 2 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

2
2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.971

Publications

1 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 158 curated pathogenic missense variants (we use a threshold of 10). The gene has 38 curated benign missense variants. Gene score misZ: 3.3724 (above the threshold of 3.09). Trascript score misZ: 2.4846 (below the threshold of 3.09). GenCC associations: The gene is linked to long QT syndrome 2, Brugada syndrome, short QT syndrome type 1, short QT syndrome, long QT syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.103696465).
BP6
Variant 7-150958278-C-A is Benign according to our data. Variant chr7-150958278-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 527096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 9 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.697G>Tp.Ala233Ser
missense
Exon 4 of 15NP_000229.1
KCNH2
NM_001406753.1
c.409G>Tp.Ala137Ser
missense
Exon 2 of 13NP_001393682.1
KCNH2
NM_172056.3
c.697G>Tp.Ala233Ser
missense
Exon 4 of 9NP_742053.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.697G>Tp.Ala233Ser
missense
Exon 4 of 15ENSP00000262186.5
KCNH2
ENST00000713710.1
c.697G>Tp.Ala233Ser
missense
Exon 4 of 15ENSP00000519013.1
KCNH2
ENST00000713701.1
c.397G>Tp.Ala133Ser
missense
Exon 3 of 14ENSP00000519004.1

Frequencies

GnomAD3 genomes
AF:
0.0000593
AC:
9
AN:
151862
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000228
AC:
18
AN:
78984
AF XY:
0.000285
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000613
AC:
80
AN:
1305430
Hom.:
2
Cov.:
32
AF XY:
0.0000885
AC XY:
57
AN XY:
643832
show subpopulations
African (AFR)
AF:
0.0000377
AC:
1
AN:
26558
American (AMR)
AF:
0.00
AC:
0
AN:
25840
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22596
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27968
South Asian (SAS)
AF:
0.00100
AC:
71
AN:
70956
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32656
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4192
European-Non Finnish (NFE)
AF:
9.61e-7
AC:
1
AN:
1040814
Other (OTH)
AF:
0.000130
AC:
7
AN:
53850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
151970
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41536
American (AMR)
AF:
0.00
AC:
0
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00165
AC:
8
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10496
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67898
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.000101
AC:
9
Asia WGS
AF:
0.000300
AC:
1
AN:
3350

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
CardioboostArm
Benign
0.0044
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
19
DANN
Benign
0.94
DEOGEN2
Benign
0.37
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.78
T
M_CAP
Pathogenic
0.91
D
MetaRNN
Benign
0.10
T
MetaSVM
Uncertain
0.69
D
MutationAssessor
Benign
0.55
N
PhyloP100
0.97
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-0.70
N
REVEL
Uncertain
0.32
Sift
Benign
0.18
T
Sift4G
Benign
0.42
T
Polyphen
0.23
B
Vest4
0.14
MutPred
0.16
Gain of phosphorylation at A233 (P = 0.0023)
MVP
0.54
MPC
0.93
ClinPred
0.020
T
GERP RS
2.6
Varity_R
0.079
gMVP
0.29
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772037564; hg19: chr7-150655366; API